Reuters India Business

BENGALURU (Reuters) – Cipla, India’s third-largest generic drugmaker by sales, reported fourth-quarter profit above expectations on Friday, driven by strong demand for its products in its key U.S. markets The company reported a 78.5% increase in net profit to 9.39 billion rupees ($112.5 million) for the quarter ended March 31, beating analysts’ estimate of 8.11 …

Indian drugmaker Cipla beats Q4 profit estimates on strong US demand Read More »

BENGALURU (Reuters) – Dr. Lal PathLabs, India’s biggest diagnostics firm by revenue, posted a bigger profit for the fourth straight quarter on Thursday, led by the addition of more labs and increased demand for medical tests. The company’s consolidated net profit jumped 49% year-on-year to 845 million rupees ($10.1 million) in the fourth quarter. Its …

India’s Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand Read More »

BENGALURU (Reuters) – Venky’s India reported a 32.8% jump in its fourth-quarter profit on Friday, benefiting from strong demand in its poultry products business amid easing costs. The Pune-based poultry company’s profit rose to 335.1 million rupees ($4 million) in the quarter ended March 31, from 252.3 million rupees a year ago, it said in …

Poultry firm Venky’s India Q4 profit rises on steady demand, easing costs Read More »

BENGALURU (Reuters) – Polycab India reported a 28.5% jump in its fourth-quarter profit on Friday, driven by strong demand for its wires and cables, its largest segment. Consolidated net profit rose to 5.46 billion rupees ($65.4 million) for the three months ended March 31 from 4.25 billion rupees a year earlier. Cables and wires companies …

Cable maker Polycab India posts Q4 profit rise on healthy demand Read More »